Leticia Barbosa Gaiotte

Ms. Leticia Barbosa Gaiotte

Instituto de Biociências - Unesp -Botucatu, Botucatu, São Paulo, Brazil

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 July 2022 in Molecules
Verified
Journal Article
Open access
PDF file
MCMaira Cucielo
Maira Cucielo
RCRoberta Carvalho Cesário
Roberta Carvalho Cesário
HSHenrique Spaulonci Silveira
Henrique Spaulonci Silveira
LGLeticia Barbosa Gaiotte
Leticia Barbosa Gaiotte
SSSergio Alexandre Alcantara Dos Santos
Sergio Alexandre Alcantara Dos Santos
Luiz Gustavo ChuffaLuiz Gustavo Chuffa
Luiz Gustavo Chuffa
Ovarian cancer (OC) is the most lethal gynecologic malignancy, and melatonin has shown various antitumor properties. Herein, we investigated the influence of melatonin therapy on energy metabolism and mitochondrial integrity in SKOV-3 cells and tested whether its effects depended on MT1 receptor activation. SKOV-3 cells were exposed to different melatonin concentrations, and experimental groups were divided as to the presence of MT1 receptors (melatonin groups) or receptor absence by RNAi silencing (siRNA MT1+melatonin). Intracellular melatonin levels increased after treatment with melatonin independent of the MT1. The mitochondrial membrane potential of SKOV-3 cells decreased in the group treated with the highest melatonin concentration. Melatonin reduced cellular glucose consumption, while MT1 knockdown increased its consumption. Interconversion of lactate to pyruvate increased after treatment with melatonin and was remarkable in siRNA MT1 groups. Moreover, lactate dehydrogenase activity decreased with melatonin and increased after MT1 silencing at all concentrations. The UCSC XenaBrowser tool showed a positive correlation between the human ASMTL gene and the ATP synthase genes, succinate dehydrogenase gene (SDHD), and pyruvate dehydrogenase genes (PDHA and PDHB). We conclude that melatonin changes the glycolytic phenotype and mitochondrial integrity of SKOV-3 cells independent of the MT1 receptor, thus decreasing the survival advantage of OC cells.